BROSHY ERAN sold 56.1% of their position (59K shares) of THERAVANCE BIOPHARMA, INC. on the open market
Open‑market sale worth $1.07M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 11/13/2025ACC: 0001256230-25-000006
-45K
Net shares
Net seller
$1.07M
Total sold
3
Open market trades
0B · 3S
4
Total transactions
14K acquired · 59K disposed
Non-Derivative Transactions3
Ordinary Shares
Direct
Shares
−29.50K
Price / share
$18.50
Trade value
$545.75K
% of position
32.3%
11/11/2025
91.20K→61.70K
Ordinary Shares
Direct
Shares
−15.50K
Price / share
$17.00
Trade value
$263.50K
% of position
25.1%
11/11/2025
61.70K→46.20K
Ordinary Shares
Direct
Shares
−14K
Price / share
$18.50
Trade value
$259K
% of position
23.3%
11/11/2025
60.20K→46.20K
Total
Net shares
−59K
Net value
-$1.07M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 11/11/2025 | S · Sale | −29.50K | $18.50 | $545.75K | 32.3% | 91.20K | 61.70K |
| Ordinary Shares Direct | 11/11/2025 | S · Sale | −15.50K | $17.00 | $263.50K | 25.1% | 61.70K | 46.20K |
| Ordinary Shares Direct | 11/11/2025 | S · Sale | −14K | $18.50 | $259K | 23.3% | 60.20K | 46.20K |
| Total | −59K | -$1.07M | ||||||
Derivative Transactions1
Share Option (Right to Buy)
Direct
Converts to
Ordinary Shares
14K shares
Shares
+14K
Strike price
10.15
Held after
107.88K
Exercisable
—
11/11/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Share Option (Right to Buy) Direct | Ordinary Shares14K shares | 11/11/2025 | M · Option Exercise | +14K | 10.15 | — | 107.88K |